ImmunoPrecise Antibodies Ltd.

Informe acción TSXV:IPA

Capitalización de mercado: CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ImmunoPrecise Antibodies Dirección

Dirección controles de criterios 2/4

Información clave

Jennifer Bath

Chief Executive Officer (CEO)

CA$1.9m

Compensación total

Porcentaje del salario del CEO34.9%
Permanencia del CEO4.8yrs
Participación del CEO0.4%
Permanencia media de la dirección1.3yrs
Promedio de permanencia en la Junta Directiva4.5yrs

Actualizaciones recientes de la dirección

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jennifer Bath en comparación con los beneficios de ImmunoPrecise Antibodies?
FechaCompensación totalSalarioIngresos de la empresa
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Compensación vs. Mercado: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Compensación vs. Ingresos: Jennifer's compensation has been consistent with company performance over the past year.

CEO

Jennifer Bath

4.8yrs

Permanencia

CA$1,856,482

Compensación

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrssin datossin datos
Carla Dahl
Vice President of Marketing1.3yrssin datos0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno datasin datos0.0048%
CA$ 7.8k

1.3yrs

Permanencia media

Equipo directivo experimentado: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00ksin datos
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrssin datossin datos
Anna Pettersson
Independent Directorless than a yearCA$75.55ksin datos

4.5yrs

Permanencia media

57yo

Promedio de edad

Junta con experiencia: IPA's board of directors are considered experienced (4.5 years average tenure).